Dual Inhibition of Autophagy and PI3K/AKT/MTOR Pathway as a Therapeutic Strategy in Head and Neck Squamous Cell Carcinoma

Genomic analyses of head and neck squamous cell carcinoma (HNSCC) have highlighted alterations in the phosphatidylinositol 3-kinase (PI3K) signaling pathway, presenting a therapeutic target for multiple ongoing clinical trials with PI3K or PI3K/MTOR inhibitors. However, these inhibitors can potentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernard, Monique, Cardin, Guillaume B., Cahuzac, Maxime, Ayad, Tareck, Bissada, Eric, Guertin, Louis, Bahig, Houda, Nguyen-Tan, Phuc Felix, Filion, Edith, Ballivy, Olivier, Soulieres, Denis, Rodier, Francis, Christopoulos, Apostolos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563873/
https://www.ncbi.nlm.nih.gov/pubmed/32825725
http://dx.doi.org/10.3390/cancers12092371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563873/
https://www.ncbi.nlm.nih.gov/pubmed/32825725
http://dx.doi.org/10.3390/cancers12092371

Ejemplares similares